Meeting
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Profile of programmed death ligand-1 (PD-L1) expression and PD-L1 gene amplification in Indonesian colorectal cancer patients.
Authors
Akterono dwi Budiyati
Stem Cell and Cancer Institute, Jakarta, Indonesia
Akterono dwi Budiyati, Teguh Pribadi Putra, Gita Dewi Kusumo, Fritzie Rexana, Antonius Kurniawan, Aru Wisaksono Sudoyo, Ahmad Rusdan Utomo, Andi Utama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies
Sub Track
Biomarkers and Inflammatory Signatures
Citation
J Clin Oncol 36, 2018 (suppl 5S; abstr 82)
DOI
10.1200/JCO.2018.36.5_suppl.82
Abstract #
82
Poster Bd #
D10
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Comparing the somatic, germline, and immune landscapes of upper tract urothelial carcinoma (UTUC) and UC of the bladder (UCB).
First Author: Kit L. Yuen
Poster
2019 Genitourinary Cancers Symposium
Evaluation of prognostic effects of MSI, PD-L1 and TIL in resected bladder cancer.
First Author: Deniz Tural
Poster
2018 ASCO Annual Meeting
Impact of MLH1, PMS2, MSH2, and MSH6 alterations on tumor mutation burden (TMB) and PD-L1 expression in 1,057 microsatellite instability-high (MSI-H) tumors.
First Author: Mohamed E. Salem
Poster
2020 ASCO Virtual Scientific Program
Prevalence and clinical characterization of MMR-D/MSI extra-colonic cancers among germline PMS2 mutation carriers.
First Author: Alicia Latham